Cidara Therapeutics Stock Forecast NASDAQ:CDTX

Price Target and Analyst Ratings

Most Recent Rating

On September 22, 2021 "Aegis" gave "$9.00 - $8.00" rating for CDTX. The price target was set to $2.25+5.1%.

Last 30 Days

Historical Ratings

Date	Rating	Action	Authority	Current Price	Target Price
2021-09-22	$9.00 - $8.00	Target Lowered by	Aegis	$2.24	$2.25+5.1%
2021-09-22	$6.25	Upgraded by	WBB Securities	$2.24	$2.14+2.4%
2021-03-10	Buy	Initiated by	Aegis	$2.60	$9.00
2021-03-04	Buy	Initiated by	Aegis	$2.34	$9.00
2021-03-04	Buy	Initiated by	Aegis	$2.34
2020-11-06	Buy	Reiterated by	Maxim Group	$2.32	$10.00
2020-08-26	Buy	Target Lowered by	Citigroup	$3.41	$6.00 → $5.00
2020-08-13	Buy	Reiterated by	Oppenheimer	$3.78	$6.00

CDTX Stock Trend

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 31.62% during the next 3 months and, with a 90% probability hold a price between $2.45 and $3.10 at the end of this 3-month period.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-30	$1.87	$2.12	$2.37
2021-10-01	$1.88	$2.13	$2.38
2021-10-04	$1.88	$2.14	$2.39
2021-10-05	$1.89	$2.14	$2.39
2021-10-06	$1.90	$2.15	$2.40
2021-10-07	$1.91	$2.16	$2.41
2021-10-08	$1.92	$2.17	$2.42
2021-10-11	$1.93	$2.18	$2.43
2021-10-12	$1.94	$2.19	$2.44
2021-10-13	$1.95	$2.20	$2.45
2021-10-14	$1.96	$2.21	$2.46
2021-10-15	$1.97	$2.22	$2.47
2021-10-18	$1.97	$2.23	$2.48
2021-10-19	$1.98	$2.23	$2.48
2021-10-20	$1.99	$2.24	$2.49
2021-10-21	$2.00	$2.25	$2.50
2021-10-22	$2.01	$2.26	$2.51
2021-10-25	$2.02	$2.27	$2.52
2021-10-26	$2.03	$2.28	$2.53
2021-10-27	$2.04	$2.29	$2.54
2021-10-28	$2.05	$2.30	$2.55
2021-10-29	$2.06	$2.31	$2.56
2021-11-01	$2.06	$2.32	$2.57
2021-11-02	$2.07	$2.32	$2.57
2021-11-03	$2.08	$2.33	$2.58
2021-11-04	$2.09	$2.34	$2.59
2021-11-05	$2.10	$2.35	$2.60
2021-11-08	$2.11	$2.36	$2.61
2021-11-09	$2.12	$2.37	$2.62
2021-11-10	$2.13	$2.38	$2.63

About Cidara Therapeutics

Cidara Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of various diseases. Its lead product candidate is CD101 IV, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of systemic Candida infections. The company also develops CD101 topical, a topical formulation of CD101 for the treatment of recurrent vul... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!